Literature DB >> 6377146

Fetal insulin balance: gestational diabetes and postpartal screening.

P A Weiss, H Hofmann, P Pürstner, R Winter, W Lichtenegger.   

Abstract

It must be determined whether high neonatal birth weight (greater than or equal to 4000 g) is due to genetic factors or to a disorder of maternal carbohydrate metabolism. Oral glucose tolerance tests are known to be unreliable during the puerperium. If the mother's carbohydrate metabolism was disturbed during pregnancy, neonatal overweight may result from fetal hyperinsulinism. This can be diagnosed by determining the insulin in the umbilical cord blood. Mature neonates of metabolically healthy women show an insulin level of 9.2 +/- 4.4 microU/ml (N = 180) in the umbilical cord blood. The third, tenth, 50th, 90th, and 97th percentiles were calculated as 1.4, 4.3, 8.8, 15.4, and 17.7 microU/ml, respectively. With insulin values over 20 microU/ml in the umbilical cord blood, a disturbance of maternal carbohydrate metabolism during pregnancy is likely. Among 4560 births in one year, 335 neonates weighed 4000 g and more, corresponding to a proportion of 7.35%. In one quarter of the infants over 4000 g, high birth weight was associated with fetal hyperinsulinism. This corresponds to a frequency of 1.8% of all births.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377146

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels.

Authors:  P A Weiss; H M Hofmann; R R Winter; W Lichtenegger; P Pürstner; J Haas
Journal:  Arch Gynecol       Date:  1986

2.  Continuous insulin delivery systems for the pregnant diabetic patient.

Authors:  H M Hofmann; P A Weiss; J G Haas
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

3.  Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus.

Authors:  Daniel K Tisi; David H Burns; Gary W Luskey; Kristine G Koski
Journal:  Diabetes Care       Date:  2010-09-20       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.